Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.45 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.44 |
| ▸ | GRM4 | Q14833 | 11/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3416643 | 0.91 | DHFR (0.49) | MCHR1NUDT1GRM4IRAK4DHFR | |
| SCHEMBL22834474 | 0.83 | NUDT1 (0.53) | NUDT1GRM4LRRK2 | |
| SCHEMBL5338216 | 0.80 | MCHR1 (0.63) | MCHR1XDHGRM4IRAK4DHFR | |
| SCHEMBL31403581 | 0.77 | MCHR1 (0.40) | MCHR1XDHGRM4IRAK4DHFR | |
| SCHEMBL3416856 | 0.77 | LRRK2 (0.43) | NUDT1GRM4LRRK2 | |
| SCHEMBL3416862 | 0.77 | LRRK2 (0.43) | NUDT1GRM4LRRK2 | |
| SCHEMBL16667809 | 0.77 | LRRK2 (0.43) | NUDT1GRM4LRRK2 | |
| SCHEMBL4936674 | 0.75 | LOXL2 (0.50) | MCHR1XDHGRM4IRAK4TLR7 | |
| SCHEMBL16051810 | 0.74 | IRAK4 (0.42) | MCHR1XDHGRM4IRAK4 | |
| SCHEMBL8277590 | 0.74 | ACACB (0.43) | MCHR1XDHGRM4IRAK4TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010068863-A2 | PYRIMIDINE COMPOUNDS AND METHODS OF MAKING AND USING SAME | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) | 2010-06-17 | — | — | WO | claimed |